Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNotes PayablesOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Jin Medical International (ZJYL) Current Assets (2022 - 2025)

Jin Medical International's Current Assets history spans 4 years, with the latest figure at -$9.2 million for Q3 2025.

  • For Q3 2025, Current Assets fell 121.55% year-over-year to -$9.2 million; the TTM value through Sep 2024 reached $42.8 million, up 37.6%, while the annual FY2025 figure was -$9.2 million, 121.55% down from the prior year.
  • Current Assets for Q3 2025 was -$9.2 million at Jin Medical International, down from $42.8 million in the prior quarter.
  • Across five years, Current Assets topped out at $42.8 million in Q3 2024 and bottomed at -$9.2 million in Q3 2025.
  • The 4-year median for Current Assets is $25.0 million (2022), against an average of $20.9 million.
  • The largest annual shift saw Current Assets soared 64.61% in 2023 before it crashed 121.55% in 2025.
  • A 4-year view of Current Assets shows it stood at $18.9 million in 2022, then surged by 64.61% to $31.1 million in 2023, then skyrocketed by 37.6% to $42.8 million in 2024, then plummeted by 121.55% to -$9.2 million in 2025.
  • Per Business Quant, the three most recent readings for ZJYL's Current Assets are -$9.2 million (Q3 2025), $42.8 million (Q3 2024), and $31.1 million (Q3 2023).